Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Auditor change

Loxo Oncology, Inc. (LOXO) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/15/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/15/2019 4 Nanda Nisha (Chief Development Officer) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Disposed/sold 18,896 shares @ $235, valued at $4.4M
Disposed/sold 16,983 options to buy @ $1.184, valued at $20.1k
Disposed/sold 14,828 options to buy @ $1.184, valued at $17.6k
Disposed/sold 4,557 options to buy @ $3.648, valued at $16.6k
Disposed/sold 10,861 options to buy @ $13.67, valued at $148.5k
Disposed/sold 9,228 options to buy @ $31.69, valued at $292.4k
Disposed/sold 14,870 options to buy @ $27, valued at $401.5k
Disposed/sold 18,375 options to buy @ $26.27, valued at $482.7k
Disposed/sold 12,000 options to buy @ $43.56, valued at $522.7k
Disposed/sold 75,000 options to buy @ $84.88, valued at $6.4M
Disposed/sold 37,000 options to buy @ $139.77, valued at $5.2M
02/15/2019 4 Naider Avi Z. (Director) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Gifted 15,000 shares @ $0
Disposed/sold 111,843 shares @ $235, valued at $26.3M
Disposed/sold 15,625 options to buy @ $13, valued at $203.1k
Disposed/sold 7,812 options to buy @ $20.91, valued at $163.3k
Disposed/sold 7,812 options to buy @ $24.18, valued at $188.9k
Disposed/sold 11,000 options to buy @ $78.58, valued at $864.4k
Disposed/sold 8,750 options to buy @ $180.98, valued at $1.6M
02/15/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/15/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/15/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/15/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/15/2019 4 Flaherty Keith T. (Director) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Disposed/sold 9,732 shares @ $235, valued at $2.3M
Disposed/sold 32,345 options to buy @ $1.184, valued at $38.3k
Disposed/sold 68,620 options to buy @ $1.184, valued at $81.2k
Disposed/sold 31,459 options to buy @ $3.648, valued at $114.8k
Disposed/sold 15,625 options to buy @ $13, valued at $203.1k
Disposed/sold 12,500 options to buy @ $13.67, valued at $170.9k
Disposed/sold 7,812 options to buy @ $20.91, valued at $163.3k
Disposed/sold 7,812 options to buy @ $24.18, valued at $188.9k
Disposed/sold 11,000 options to buy @ $78.58, valued at $864.4k
Disposed/sold 2,500 options to buy @ $84.88, valued at $212.2k
Disposed/sold 8,750 options to buy @ $180.98, valued at $1.6M
02/15/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/15/2019 4 Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Disposed/sold 17,500 options to buy @ $11.35, valued at $198.6k
Disposed/sold 28,000 options to buy @ $26.27, valued at $735.6k
Disposed/sold 28,000 options to buy @ $31.69, valued at $887.3k
Disposed/sold 12,000 options to buy @ $43.56, valued at $522.7k
Disposed/sold 40,000 options to buy @ $84.88, valued at $3.4M
Disposed/sold 20,000 options to buy @ $139.77, valued at $2.8M
02/15/2019 4 Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Disposed/sold 162,707 shares @ $235, valued at $38.2M
Disposed/sold 30,000 shares @ $235, valued at $7.1M
Disposed/sold 27,459 options to buy @ $1.184, valued at $32.5k
Disposed/sold 64,471 options to buy @ $3.648, valued at $235.2k
Disposed/sold 318,514 options to buy @ $13.67, valued at $4.4M
Disposed/sold 142,000 options to buy @ $31.69, valued at $4.5M
Disposed/sold 209,000 options to buy @ $26.27, valued at $5.5M
Disposed/sold 100,000 options to buy @ $43.56, valued at $4.4M
Disposed/sold 300,000 options to buy @ $84.88, valued at $25.5M
Disposed/sold 128,000 options to buy @ $139.77, valued at $17.9M
01/17/2019 4/A Van Naarden Jacob (COO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Exercised 1,541 shares @ $3.648, valued at $5.6k
01/17/2019 4/A Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Exercised 7,500 shares @ $1.184, valued at $8.9k
01/02/2019 4 Nanda Nisha (Chief Development Officer) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Granted 37,000 options to buy @ $139.77, valued at $5.2M
01/02/2019 4 Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Granted 20,000 options to buy @ $139.77, valued at $2.8M
01/02/2019 4 Van Naarden Jacob (COO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Granted 57,000 options to buy @ $139.77, valued at $8M
01/02/2019 4 Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Granted 128,000 options to buy @ $139.77, valued at $17.9M
01/02/2019 3 Nanda Nisha (Chief Development Officer) has filed a Form 3 on Loxo Oncology, Inc.
12/17/2018 4 Naider Avi Z. (Director) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Bought 725 shares @ $138.9185, valued at $100.7k
12/12/2018 4 Van Naarden Jacob (Chief Business Officer) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 400 shares @ $130.59, valued at $52.2k
Sold 1,000 shares @ $132.23, valued at $132.2k
Sold 900 shares @ $133.17, valued at $119.9k
Sold 1,400 shares @ $134.65, valued at $188.5k
Sold 500 shares @ $135.14, valued at $67.6k
Sold 200 shares @ $136.48, valued at $27.3k
Sold 100 shares @ $137.39, valued at $13.7k
Sold 400 shares @ $134.74, valued at $53.9k
Sold 800 shares @ $135.92, valued at $108.7k
Sold 1,759 shares @ $137.09, valued at $241.1k
Sold 500 shares @ $137.73, valued at $68.9k
12/12/2018 4 Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 100 shares @ $130.79, valued at $13.1k
Sold 400 shares @ $132.44, valued at $53k
Sold 100 shares @ $133.34, valued at $13.3k
Sold 550 shares @ $134.71, valued at $74.1k
Sold 100 shares @ $136.04, valued at $13.6k
Sold 200 shares @ $135.69, valued at $27.1k
Sold 587 shares @ $136.98, valued at $80.4k
Sold 263 shares @ $137.88, valued at $36.3k
Sold 100 shares @ $139.36, valued at $13.9k
Sold 100 shares @ $140.48, valued at $14k
Exercised 1,250 options to buy @ $11.35, valued at $14.2k
12/12/2018 4 Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 969 shares @ $130.58, valued at $126.5k
Sold 2,001 shares @ $132.09, valued at $264.3k
Sold 2,104 shares @ $133, valued at $279.8k
Sold 2,049 shares @ $134.31, valued at $275.2k
Sold 2,377 shares @ $135.04, valued at $321k
Sold 400 shares @ $136.48, valued at $54.6k
Sold 100 shares @ $137.39, valued at $13.7k
Sold 647 shares @ $134.63, valued at $87.1k
Sold 1,153 shares @ $135.76, valued at $156.5k
Sold 3,393 shares @ $136.79, valued at $464.1k
Sold 2,407 shares @ $137.63, valued at $331.3k
11/28/2018 4 Van Naarden Jacob (Chief Business Officer) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 1,556 shares @ $151.71, valued at $236.1k
Sold 1,644 shares @ $152.49, valued at $250.7k
Sold 1,500 shares @ $154, valued at $231k
Sold 600 shares @ $155.3, valued at $93.2k
Sold 200 shares @ $156.45, valued at $31.3k
Sold 949 shares @ $138.08, valued at $131k
Sold 1,170 shares @ $138.83, valued at $162.4k
Sold 300 shares @ $140.13, valued at $42k
Sold 500 shares @ $141.69, valued at $70.8k
Sold 500 shares @ $143.08, valued at $71.5k
Sold 200 shares @ $143.92, valued at $28.8k
11/28/2018 4 Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 500 shares @ $151.57, valued at $75.8k
Sold 250 shares @ $152.39, valued at $38.1k
Sold 100 shares @ $153.3, valued at $15.3k
Sold 300 shares @ $155.13, valued at $46.5k
Sold 100 shares @ $156.04, valued at $15.6k
Sold 200 shares @ $137.89, valued at $27.6k
Sold 350 shares @ $138.95, valued at $48.6k
Sold 200 shares @ $140.94, valued at $28.2k
Sold 200 shares @ $143.84, valued at $28.8k
Sold 100 shares @ $147.09, valued at $14.7k
Sold 100 shares @ $148.2, valued at $14.8k
11/28/2018 4 Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Exercised 8,514 shares @ $3.648, valued at $31.1k
Sold 800 shares @ $150.99, valued at $120.8k
Sold 3,655 shares @ $152.04, valued at $555.7k
Sold 1,995 shares @ $152.75, valued at $304.7k
Sold 676 shares @ $154.07, valued at $104.2k
Sold 2,210 shares @ $155.08, valued at $342.7k
Sold 664 shares @ $156.2, valued at $103.7k
Sold 2,329 shares @ $137.92, valued at $321.2k
Sold 2,638 shares @ $138.94, valued at $366.5k
Sold 700 shares @ $140.14, valued at $98.1k
Sold 690 shares @ $141.48, valued at $97.6k
10/05/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2018 4 Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 590 shares @ $165.5278, valued at $97.7k
Sold 100 shares @ $167.1, valued at $16.7k
Sold 560 shares @ $168.9723, valued at $94.6k
Sold 539 shares @ $161.2155, valued at $86.9k
Sold 311 shares @ $162.5366, valued at $50.5k
Sold 200 shares @ $164.25, valued at $32.9k
Sold 200 shares @ $165.05, valued at $33k
Exercised 1,250 options to buy @ $11.35, valued at $14.2k
Exercised 1,250 options to buy @ $11.35, valued at $14.2k
10/05/2018 4 Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Exercised 10,000 shares @ $3.648, valued at $36.5k
Sold 2,905 shares @ $165.0058, valued at $479.3k
Sold 1,225 shares @ $165.9477, valued at $203.3k
Sold 673 shares @ $167.0908, valued at $112.5k
Sold 1,297 shares @ $168.2902, valued at $218.3k
Sold 3,705 shares @ $169.003, valued at $626.2k
Sold 195 shares @ $169.6779, valued at $33.1k
Sold 1,700 shares @ $160.6138, valued at $273k
Sold 1,553 shares @ $161.4096, valued at $250.7k
Sold 3,152 shares @ $162.6041, valued at $512.5k
Sold 2,000 shares @ $163.6428, valued at $327.3k
10/03/2018 4 Kunkel Lori Anne (Director) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 4,500 shares @ $170.1958, valued at $765.9k
Sold 500 shares @ $171.896, valued at $85.9k
Exercised 5,000 options to buy @ $3.648, valued at $18.2k
09/14/2018 4 Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 550 shares @ $166.1391, valued at $91.4k
Sold 200 shares @ $167.25, valued at $33.5k
Sold 200 shares @ $168.785, valued at $33.8k
Sold 300 shares @ $170.95, valued at $51.3k
Sold 750 shares @ $165.5267, valued at $124.1k
Sold 500 shares @ $166.756, valued at $83.4k
Exercised 1,250 options to buy @ $11.35, valued at $14.2k
Exercised 1,250 options to buy @ $11.35, valued at $14.2k
09/14/2018 4 Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 700 shares @ $164.1594, valued at $114.9k
Sold 3,700 shares @ $165.1821, valued at $611.2k
Sold 2,400 shares @ $166.4875, valued at $399.6k
Sold 1,800 shares @ $167.3814, valued at $301.3k
Sold 800 shares @ $168.5125, valued at $134.8k
Sold 200 shares @ $169.8872, valued at $34k
Sold 400 shares @ $171.075, valued at $68.4k
Sold 5,636 shares @ $165.425, valued at $932.3k
Sold 3,402 shares @ $166.523, valued at $566.5k
Sold 962 shares @ $167.3169, valued at $161k
Exercised 10,000 options to buy @ $1.184, valued at $11.8k
09/14/2018 4 Van Naarden Jacob (Chief Business Officer) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 756 shares @ $164.4383, valued at $124.3k
Sold 1,885 shares @ $165.3156, valued at $311.6k
Sold 1,059 shares @ $166.738, valued at $176.6k
Sold 1,000 shares @ $167.392, valued at $167.4k
Sold 200 shares @ $168.785, valued at $33.8k
Sold 600 shares @ $171.0267, valued at $102.6k
Sold 2,700 shares @ $165.4463, valued at $446.7k
Sold 1,500 shares @ $166.6347, valued at $250k
Sold 300 shares @ $167.4867, valued at $50.2k
Exercised 5,500 options to buy @ $3.648, valued at $20.1k
Exercised 4,500 options to buy @ $3.648, valued at $16.4k
08/15/2018 4 Van Naarden Jacob (Chief Business Officer) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 730 shares @ $157.6155, valued at $115.1k
Sold 3,070 shares @ $158.6619, valued at $487.1k
Sold 1,500 shares @ $159.6893, valued at $239.5k
Sold 200 shares @ $160.595, valued at $32.1k
Sold 600 shares @ $159.082, valued at $95.4k
Sold 3,199 shares @ $159.907, valued at $511.5k
Sold 701 shares @ $160.6997, valued at $112.7k
Exercised 5,500 options to buy @ $3.648, valued at $20.1k
Exercised 4,500 options to buy @ $3.648, valued at $16.4k
08/15/2018 4 Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 800 shares @ $158.0025, valued at $126.4k
Sold 440 shares @ $158.6882, valued at $69.8k
Sold 10 shares @ $160.17, valued at $1.6k
Sold 450 shares @ $159.4656, valued at $71.8k
Sold 800 shares @ $160.6488, valued at $128.5k
Exercised 1,250 options to buy @ $11.35, valued at $14.2k
Exercised 1,250 options to buy @ $11.35, valued at $14.2k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy